Rice University bioengineering students are making a critical procedure easier for airway managers and safer for patients with a simplified, high-tech intubation device.   The Gateway to Airway team at Rice, working with an anesthesiologist, has developed a sleek laryngoscope that simplifies intubating patients for scheduled or emergent procedures.   The handheld, 3D-printed device contains a miniature wireless camera. Clinicians can use a switch on the comfortable handle to adjust the light from an LED near the camera, which...

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells. Their findings could have significant benefits for patients with disease progression. This research, which spans preclinical and clinical studies, represents the largest analysis to date of MDS patient samples. If further validated in larger clinical trials, the data...

Details about variants hiding in the deluge of genetic SARS-CoV-2 sequences would be good to know, if only researchers a new program developed by Rice University’s George R. Brown School of Engineering will make it possible, at least for “intrahost variants,” those that appear in genome data from the same COVID-19-positive person. A Rice team led by computer scientist Todd Treangen and graduate student Yunxi Liu has developed Variabel, which accurately identifies “low-frequency variants” of the virus that causes COVID-19....

Acute myeloid leukemia (AML) is the most common leukemia in adults and, despite advances in targeted therapies, is associated with poor prognoses. Immunotherapy has shown promise, especially in combination with chemotherapy. A research team led by V. Lokesh Battula, Ph.D., demonstrated that the immune checkpoint protein B7-H3 may serve as a potential immunotherapy target in patients with AML. The team found elevated expression of B7-H3 to be associated with poor treatment outcomes in patients with AML. In preclinical studies,...

A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone. A study by scientists at Rice University and Baylor College of Medicine demonstrated the effective treatment of such cancers in rodent models, bringing hope for new therapies to treat bone metastases. The open-access study advances techniques pioneered by Rice chemist Han Xiao and his co-author at Baylor, biologist Xiang Zhang. They discovered through extensive testing that...

A study led by researchers at The University of Texas MD Anderson Cancer Center reported that the MEK inhibitor trametinib reduced the risk of disease progression or death by 52% compared to standard-of-care therapies for the treatment of low-grade serous ovarian carcinoma. The international, multi-center Phase II/III trial led by David Gershenson, M.D., professor of Gynecologic Oncology & Reproductive Medicine, is the first positive randomized clinical trial of any therapy to demonstrate significantly increased progression-free survival (PFS) and objective...

In a new study, researchers found evidence that HPV vaccination is reducing the incidence of anal cancer among young adults in the US. Researchers at the University of Texas Medical Branch analyzed data from the US Cancer Statistics database from 2001 to 2018 to examine anal cancer incidences among different age groups and determine the potential impact of HPV vaccination. They found that cancer incidence among young adults 20 to 44 years of age began to rapidly and significantly decrease within...

A blood test, combined with a risk model based on an individual’s history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study led by researchers from The University of Texas MD Anderson Cancer Center. A personalized lung cancer risk assessment, combining a blood test based on a four-marker protein panel developed at MD Anderson and an independent model (PLCOm2012) that accounts for smoking history, was more sensitive and...

Houston Methodist Sugar Land Hospital in Fort Bend County is using an innovative, minimally invasive technique to treat chronic subdural hematomas, serious bleeding in the membrane between the skull and the brain caused by head trauma. Board-certified neurosurgeon Tsz Yeung Lau, M.D., recently performed a successful meningeal artery embolization (MAE) to stop a patient’s bleeding. The patient – a woman in her 80s – was on blood thinners for a heart condition and had recently...

Dr. Eric Walser will debut a new treatment for prostate cancer that uses focused ultrasound beams rather than needles or incisions. “This is a radical new therapy which also shows promise and is approved for the treatment of essential tremors and Parkinson’s disease,” said Walser, chair of Radiology and director of the Interventional Radiology Department at the University of Texas Medical Branch. “We see future applications for brain cancer and cancer in other parts of the body....